Home Podcasts Wall Street Wildlife Investing Podcast
Wall Street Wildlife Investing Podcast

Wall Street Wildlife Investing Podcast

Krzysztof and Luke 216 Episodes Jun 28, 2026

Stop gambling with your money and learn proven stock market investing strategies from two professionals with 40+ years of combined experience. Each episode provides expert financial advice, going beyond the hype to reveal the secrets to identifying the world's top-performing companies (and weeding out the trash). Whether you're considering investing for beginners or looking to sharpen your investing knowledge, we are here to guide you. Subscribe today and gain the edge you need to build lasting wealth in today's market.

Episodes

The Glowing Eyeball vs the Obesity Drug: $SPHR and $NVO Debated (E138) Jun 28, 2026 00:50:23 Two companies making the world genuinely better — one a glowing eyeball printing money in the desert, the other a century-old drug giant that invented the obesity revolution. So why are both kind of terrible investments right now? Luke and Krzysztof go head-to-head on $SPHR (Sphere Entertainment) and $NVO (Novo Nordisk) in this week's King of the Jungle bull-bear debate — and the tension is re
Is $EOSE an 11-Bagger That's Just Getting Started? (E137) Jun 21, 2026 01:11:26 Two years ago, Badger called EOS Energy garbage. Monkey wouldn't shut up about it. Today, the stock is up 1,000% and the story is just getting stronger. This week on Wall Street Wildlife, we settle the $EOSE vs $AXON bet, dissect a rights offering that could make or break $EOSE shareholders, and go live on SpaceX IPO day to watch history happen in real time.🚀 SpaceX opens at $160+ on IPO day —
Is the SpaceX IPO a Trap for Retail Investors? + $NU + $MRLN (E136) Jun 14, 2026 01:04:47 SpaceX is finally going public and it might be the most hyped IPO in a generation. But does that make it a buy, a trade, or a trap? Luke and Krzysztof have completely different plans, and neither one is obvious. This week also covers a tiny autonomous aviation startup that jumped 30% on a massive red day, why Luke dumped $WISE and owns $NU instead, and why the easy money on big IPOs is almost neve
Welcome to the Wall Street Wildlife Investing Podcast Jun 12, 2026 00:01:03 Where the worlds of technology, business, finance, stock markets, and animal spirits collide.Perfect for those who know there’s an intelligent and principled way to become wealthy but haven’t yet had a good jungle guide, Luke ‘The Badger 🦡’ Hallard and Krzysztof ‘Monkey 🍌’ Piekarski bring you investing insights and principles to help you better understand how to make $$ money in the stock market.W
Is IREN Becoming a Serious AI Cloud Contender? + Buying SpaceX Pre-IPO + $WISE (E135) Jun 7, 2026 01:17:18 The AI infrastructure land grab is accelerating — and this week, Krzysztof drops a deep dive into his #1 portfolio holding that rewrites the bull case entirely. Meanwhile, Luke's longtime fintech darling just got hit with a half-billion-euro money laundering investigation on the same week it relisted on NASDAQ. Timing couldn't be worse. Here's what's really at stake:🤖 $IREN just we
What Four Expert Investors Own Right Now $NVDA $AXON $CRWD $ASTS $RKLB $VOO (E134) May 30, 2026 01:29:40 Four investors. Four wildly different portfolios. One crossover episode that gets uncomfortably honest about conviction, concentration, and whether the rules of investing have actually changed. Wall Street Wildlife's Luke and Krzysztof team up with Bear and Drowsy from Shooting the Bull Pod — and the result is one of the most candid portfolio conversations we've ever recorded.🤖 One investor is sit
Is This $2.4B Biotech About to Explode? + $MELI & $ISRG (E133) May 24, 2026 01:18:03 Three stocks, three debates, one ticking clock. This week on Wall Street Wildlife, Krzysztof drops a live biotech catalyst with a 24-hour window, Luke defends his 20-year 'sugar daddy' holding, and a Latin American e-commerce giant is quietly being stress-tested. Plus: Krzysztof reveals a wild AI experiment he's launching in public — and betting real money against it.💊 Luke's been
Four Stocks, Two Hosts, Zero Sugarcoating — Bull vs. Bear (E132) May 17, 2026 01:02:24 Four companies. Two hosts. One brutal question: which stocks deserve your conviction right now, and which ones are just good stories hiding ugly fundamentals? This week, Luke and Krzysztof go bull-vs-bear on four names — and the conclusions might surprise you. The "too hard pile" is getting bigger, and maybe that's the smartest move in this market.🎴 Luke's brutal poker night beco
Is $WISE About to Explode on the NASDAQ? (E131) May 10, 2026 00:20:11 The largest UK fintech is abandoning the London Stock Exchange for the NASDAQ — and Luke thinks it could be an inflection point. This solo deep-dive makes the bull AND bear case on one of his highest-conviction holdings, right before the dual listing goes live. Here's what every investor needs to know before May 11th.💰 Why $WISE is ditching London for the NASDAQ — and what it means for shareholder
The AI Math Is Brutal – Is Half Your Portfolio Already Dead? + $POET's Wild Week (E130) May 3, 2026 01:07:44 Luke sold two stocks this week. Not because earnings disappointed or guidance missed — but because he ran the numbers on what AI actually does to software valuations, and the math got uncomfortable fast. Meanwhile, Krzysztof turned a 70% options loss into a breakeven exit... then watched the stock moon another 60%... then crater 50% — all in the same week. This is what investing in the AI era actu
Is $NKTR the Most Undervalued Biotech Nobody's Talking About? (E129) Apr 26, 2026 01:08:32 200 million eczema sufferers. A leading drug that fails more than half of them. A cancer-causing alternative that still projects $5 billion in sales. And a tiny 60-person San Francisco biotech that may have cracked the code — with a Nobel Prize-validated mechanism the market is somehow pricing at near-zero. This week, Krzysztof goes full deep-dive on Nectar Therapeutics ($NKTR), while Luke — self-
Is AI Crushing Cybersecurity? $CRWD $PANW Face the Music (E128) Apr 19, 2026 00:53:13 The AI arms race is here, and it's shaking up the cybersecurity landscape. Is it time to panic, or is this a buying opportunity? We dive deep into the AI doomsday fears and how it could impact our portfolios.Plus:🧠 Axon's stock-based comp problem: a great company, TERRIBLE stock? $AXON📊 Wise's Nasdaq listing is imminent: what does it mean for investors? $WISE $WIZEY💊 Krzysztof's se

Recommended